Morgan Stanley estimated in 2024 that employer GLP-1 coverage generates USD 8,200 in annual healthcare cost savings per successfully treated employee with obesity generating positive ROI within 3 to 5 years
Loss of PDIA1 increases sulfenylation of Drp1 at Cys644 and enhances Drp1 activity, promoting mitochondrial fragmentation and mtROS production, which ultimately leads to endothelial cell dysfunction (Kim YM
The researchers studying sea sponge biology weren't trying to cure leukemia, yet their work became essential to cancer treatment
10.3389/fnut.2020.00164 6
Compounded Semaglutide Injection is $189/mo month-to-month (or $149/mo on the 6-month plan) and remains flat across all dose levelsyour dose may need to go up, but your price won't
While emerging preclinical research suggests potential anti-inflammatory properties, there is currently no FDA-approved indication for GLP-1 medications in treating Crohn's disease or any inflammatory bowel disease